Drugs / buffered lidocaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02209272 Comparator | Aug 2014 → Feb 2018 | osteoarthritis, hip | Mayo Clinic | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buffered lidocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02209272 ↗ |
| Modality | Other / unclassified | “Lidocaine is the most commonly used local anesthetic in most medical practices” NCT02209272 ↗ |
| Route | Other | “intraarticular hip injections” NCT02209272 ↗ |